These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17119036)

  • 21. Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer.
    Bewick MA; Conlon MS; Lafrenie RM
    J Clin Oncol; 2006 Dec; 24(36):5645-51. PubMed ID: 17116943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer.
    Bewick MA; Conlon MS; Lafrenie RM
    Breast Cancer Res Treat; 2008 Sep; 111(1):93-101. PubMed ID: 17922231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional plasminogen activator inhibitor-1 gene variants and breast cancer survival.
    Zhang X; Shu XO; Cai Q; Ruan Z; Gao YT; Zheng W
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6037-42. PubMed ID: 17062678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers.
    Huang CS; Kuo SH; Lien HC; Yang SY; You SL; Shen CY; Lin CH; Lu YS; Chang KJ
    Oncologist; 2008 Jul; 13(7):751-60. PubMed ID: 18614591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor polymorphisms and the risk of endometrial cancer.
    Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
    BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of common PALB2 polymorphisms with breast cancer risk: a case-control study.
    Chen P; Liang J; Wang Z; Zhou X; Chen L; Li M; Xie D; Hu Z; Shen H; Wang H
    Clin Cancer Res; 2008 Sep; 14(18):5931-7. PubMed ID: 18794107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study.
    Cai Q; Kataoka N; Li C; Wen W; Smith JR; Gao YT; Shu XO; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):27-32. PubMed ID: 18199708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential roles of Angiotensinogen and Angiotensin Receptor type 1 polymorphisms in breast cancer risk.
    González-Zuloeta Ladd AM; Arias Vásquez A; Siemes C; Yazdanpanah M; Coebergh JW; Hofman A; Stricker BH; van Duijn CM
    Breast Cancer Res Treat; 2007 Mar; 101(3):299-304. PubMed ID: 16823505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
    Willems P; Claes K; Baeyens A; Vandersickel V; Werbrouck J; De Ruyck K; Poppe B; Van den Broecke R; Makar A; Marras E; Perletti G; Thierens H; Vral A
    Genes Chromosomes Cancer; 2008 Feb; 47(2):137-48. PubMed ID: 18000863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
    Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of genetic variations in aromatase gene with serum estrogen and estrogen/testosterone ratio in Chinese elderly men.
    Jiang J; Tang NL; Ohlsson C; Eriksson AL; Vandenput L; Chan FW; Ching JK; Kwok A; Orwoll E; Kwok TC; Woo J; Leung PC
    Clin Chim Acta; 2010 Jan; 411(1-2):53-8. PubMed ID: 19818337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
    Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
    Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese.
    Li Y; Liang J; Kang S; Dong Z; Wang N; Xing H; Zhou R; Li X; Zhao X
    Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 genotypes and haplotypes associated with risk of breast cancer.
    Buyru N; Altinisik J; Demokan S; Dalay N
    Cancer Detect Prev; 2007; 31(3):207-13. PubMed ID: 17574348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
    De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
    Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.
    Han S; Lee KM; Choi JY; Park SK; Lee JY; Lee JE; Noh DY; Ahn SH; Han W; Kim DH; Hong YC; Ha E; Yoo KY; Kang D
    Breast Cancer Res Treat; 2008 Jul; 110(2):387-93. PubMed ID: 17940865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement.
    Lee KM; Choi JY; Lee JE; Noh DY; Ahn SH; Han W; Yoo KY; Hayes RB; Kang D
    Breast Cancer Res Treat; 2007 Dec; 106(3):433-8. PubMed ID: 17262178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients.
    Zhou W; Heist RS; Liu G; Neuberg DS; Asomaning K; Su L; Wain JC; Lynch TJ; Giovannucci E; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2239-45. PubMed ID: 17119052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.
    Kim JY; Lee CS; Kim HO; Jo YH; Lee J; Jung MH; Baik HH; Choe W; Kang I; Yoon KS
    Oncol Rep; 2009 Sep; 22(3):487-92. PubMed ID: 19639193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
    Riaz M; Berns EM; Sieuwerts AM; Ruigrok-Ritstier K; de Weerd V; Groenewoud A; Uitterlinden AG; Look MP; Klijn JG; Sleijfer S; Foekens JA; Martens JW
    Breast Cancer Res Treat; 2012 Jun; 133(3):843-51. PubMed ID: 21748294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.